Neil Torres

Director/Board Member at

Systems Oncology LLC

Consumer Services

Finance

Health Technology

Profile

Neil Torres is currently the Director at Systems Oncology LLC and Principal at The Pritzker Organization LLC since 2002.
Mr. Torres completed undergraduate education at The University of Chicago in 2002.

Neil Torres active positions

Companies	Position	Start
Systems Oncology LLC Systems Oncology LLC BiotechnologyHealth Technology Researches and develops cancer drugs	Director/Board Member	-
The Pritzker Organization LLC The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest.	Private Equity Investor	31/05/2002

All active positions of Neil Torres

Training of Neil Torres

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Neil Torres's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
The University of Chicago The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Pritzker Organization LLC The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest.	Finance
Systems Oncology LLC Systems Oncology LLC BiotechnologyHealth Technology Researches and develops cancer drugs	Health Technology

See company connections